CompletedNot Applicable

Prospective Study of the Impact of Systemic Corticosteroid Use on Measures of Sleep Disordered Breathing

Israel20 participantsStarted 2007-01

Plain-language summary

Weight gain is both a significant risk factor for obstructive sleep apnea and a side-effect of long-term systemic steroids therapy. This study aimed to investigate the impact of long-term systemic steroid treatment on sleep apnea.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * For inclusion, a scheduled therapy with a minimum daily dose of 10 mg prednisone (or equivalent) for at least 3 months was required Exclusion Criteria: * Patients younger than 18 years and those with known sleep apnea or other forms of sleep-disordered breathing were excluded

What they're measuring

apnea-hypopnea index

Timeframe: 3 months

Trial details

NCT IDNCT01228695

SponsorRambam Health Care Campus

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-01

View on ClinicalTrials.gov More Sleep Apnea trials